• Professor Nick Ward: Countering the chronic shortage of rehabilitation services
    Therapy19 May

    Stroke is the leading cause of long-term neurological disability worldwide.1,2 One in four adults will experience a stroke and closer to one in three will have some form of acquired brain injury (including stroke, traumatic brain injury, brain tumours). By Nick Ward, Professor of Clinical Neurology and Neurorehabilitation at Queen Square Two-thirds of people experiencing [...]

  • Making FND make sense – why understanding a patient’s family, friends and life are vital to functional gains
    Research16 May

    By Consultant Clinical Neuropsychologist at PJ Care, Estefania Triguero Throughout my 15-year career in neurorehabilitation, understanding a patient as a unique individual has always been key. Whether they have a neurological condition or an acquired brain injury caring for that individual requires a compassionate, holistic and person-centred approach. A patient’s family and friends typically play [...]

  • Harry’s Pals partners with Slater and Gordon
    Brain injury16 May

    A charity which delivers emotional support to parents of seriously ill or disabled children is able to grow its life-changing provision even further through a new partnership. Harry’s Pals offers a unique service which helps parents to negotiate the hugely challenging times after their child receives a devastating diagnosis – something which has a significant [...]

  • Professor Louise Connell: Rewriting the future of rehabilitation with Neurorehabilitation Online
    Therapy16 May

    In a health system often focused on treating illness rather than supporting recovery, Professor Louise Connell is making rehabilitation impossible to ignore. A clinical academic physiotherapist and Professor of Allied Health Rehabilitation at Lancaster University and East Lancashire Hospitals NHS Trust, Professor Connell has spent more than two decades working at the intersection of research [...]

  • Campaign launches as children risk losing life-changing therapy
    Research14 May

    With the closure of essential therapy providers like the National Bobath Cerebral Palsy Centre, families of children with movement disorders are facing a devastating crisis. Vital specialist services are vanishing due to chronic underfunding, leaving parents scrambling to find the support their children desperately need. Disability charities are under unprecedented strain. With little to no [...]

  • Mitochondrial DNA editing is a breakthrough in tackling neurodegenerative diseases
    Research14 May

    Mitochondrial DNA (mtDNA) editing has emerged as a revolutionary approach in the fight against neurodegenerative diseases. As these diseases continue to impose a significant global health burden, the innovative use of mitochondrial gene editing offers a promising avenue to address their underlying causes.  The dysfunction of mitochondria, triggered by mutations in mtDNA, is now recognised [...]

  • How obstructive sleep apnoea affects memory and brain function
    Research14 May

    Obstructive sleep apnoea, commonly associated with cardiovascular and metabolic diseases, also plays a significant but less recognised role in memory decline, according to a new review. Researchers have reviewed evidence from human and animal studies showing that OSA patients often experience notable memory impairments, particularly in visual and verbal working memory. They report that key [...]

  • Identifying the first reliable biomarker for depression
    Brain injury13 May

    While there are currently biomarkers that have been identified for depression, they are not generally reliable and have, so far, not been widely applied in clinical use. Now, researchers have identified what could be the first reliable biomarker for the condition - potentially transforming its diagnosis and treatment. The brain uses networks to coordinate its [...]

  • Rebuilding a life after brain injury: Mark’s story
    Brain injury13 May

    SweetTree Home Care Services reveal how adopting a structured, outcome-driven approach helped Mark rebuild his life after brain injury. Rebuilding a life after brain injury: Mark's story Imagine forgetting basic skills—how to brush your teeth, make a cup of tea, or even where you live. For Mark, a 49-year-old man living in London with temporal [...]

  • Treatment for Huntington’s Disease achieves primary end point in clinical trial
    Huntington's13 May

    Results from the Phase 2 PIVOT-HD study of PTC518 (votoplam) in Stage 2 and Stage 3 Huntington's disease (HD) patients demonstrated that the treatment met its primary endpoint of reduction in blood Huntingtin (HTT) protein levels. The treatment showed a reduction in HTT protein levels at Week 12 and favourable safety and tolerability. The 12-month [...]